Connect with us

Utah

Utah Republicans ignore study supporting gender-affirming care for trans youth. It's research they demanded

Published

on

Utah Republicans ignore study supporting gender-affirming care for trans youth. It's research they demanded


Utah’s Republican leaders, who banned access to medically recommended care for trans minors, spent more than two years demanding proof that gender-affirming hormone therapy benefits transgender youth. Now they have it — and they’re still refusing to budge.

Keep up with the latest in LGBTQ+ news and politics. Sign up for The Advocate’s email newsletter.

A comprehensive, state-commissioned report released last week shows that gender-affirming care leads to better mental health and lower suicide risk among transgender minors. But instead of lifting the state’s ban, GOP lawmakers are doubling down on a policy that doctors, advocates, and families have long warned is putting lives at risk.

Department of Health and Human Services deletes mental health report on Utah’s transgender children
What is gender-affirming care, who uses it, and do they regret it?

What’s in the report

The more than 1,000-page report, conducted by the University of Utah’s Drug Regimen Review Center and quietly posted online Monday by the Utah Department of Health and Human Services, was required by S.B. 16 — the 2023 law that banned most gender-affirming medical care for minors. At the time, Republican Gov. Spencer Cox called the law a “nuanced” approach and insisted the state needed more data. Now that the data is in, his office has gone silent.

The report eviscerates the claims Republicans used to pass the ban in the first place.

Advertisement

“The conventional wisdom among non-experts has long been that there are limited data on the use of [gender-affirming hormone therapy] in pediatric patients,” the researchers wrote. “However, results from our exhaustive literature searches have led us to the opposite conclusion.” The study found over 230 primary studies involving 28,056 trans youth — “far exceeding” the evidence that typically supports FDA approval for high-risk pediatric treatments, including gene therapy.

“The body of evidence we have uncovered exceeds the amount of evidence that often serves as the basis of FDA approval for many high-risk, new drugs approved in pediatric populations in the U.S.,” the authors added.

The report emphasized that such treatments are not given to prepubertal children, that puberty blockers and hormones are typically initiated only in early or mid-adolescence, and that surgeries — especially bottom surgeries — are not recommended for minors. The review also found no significant long-term safety concerns, and that “regret” associated with treatment is extremely rare. In fact, among the 32 studies examining regret, researchers found it was “virtually nonexistent” — and when present, it was “only a very minor proportion” of treatment discontinuation.

Utah Republicans reject their own commissioned review

The report’s release was met with no public response from Cox or legislative leaders, The Salt Lake Tribune reports.

Republican state Reps. Katy Hall and Bridger Bolinder, who helped pass the law, dismissed the findings outright in a joint statement. “The science isn’t there,” they claimed. “The risks are real, and the public is with us.”

Advertisement

Trump administration announces end to gender-affirming care for transgender veterans

State Senate President Stuart Adams echoed their skepticism. “Utah enacted a law to safeguard the long-term health and well-being of minors while providing time to carefully examine the evolving medical landscape surrounding novel and irreversible procedures for minors,” he said, according to the Tribune.

State Rep. Mike Kennedy, the bill’s lead sponsor and a physician, declined to comment to the paper.

LGBTQ+ rights advocates say the report dismantles GOP’s justification for care bans

Chris Erchull, senior attorney at GLAD Law, told The Advocate that the report’s conclusion is straightforward.“This is the most comprehensive and the most recent review of all of the studies on care that’s been provided to transgender young people over many decades,” Erchull said. “It confirms what many providers and families already knew — that the standards of care for young transgender people provide benefits to their overall health and well-being. All of these attempts to block access to care for transgender young people have been causing harm. And any future attempts will also cause harm.”

But the science is there. The review found that youth who received care before age 18 had better outcomes, especially around depression, anxiety, and suicidality. Hormonal treatments were associated with positive mental health and psychosocial functioning outcomes. “When left untreated, individuals with gender dysphoria may experience psychological and social harms,” the report notes.

Shannon Minter, legal director of the National Center for Lesbian Rights, called the Utah report “by far the most detailed, thorough, and comprehensive review of the medical evidence relating to transgender healthcare.”

Advertisement

“This review shows that when the evidence is viewed objectively, there is no serious question that this care is safe, effective, and medically necessary for some youth,” Minter told The Advocate. “The report also makes clear that if legislators are concerned about this care, they can implement guardrails to ensure that it is being prescribed consistently with the standards of care.”

Minter added that while the report came too late to be submitted in the U.S. Supreme Court’s review of United States v. Skrmetti, it offers “an incredibly helpful counterpoint to the incomplete and distorted coverage of this care that has dominated the mainstream press.”

“The data show overwhelmingly that the people who need this care benefit significantly from it”

Erchull said the report also rebuts widespread misinformation.

“One of the biggest misconceptions is that this care is easy to access and handed out without oversight,” he said. “But the study tells us something very important: regret rates are exceedingly low. People may hear powerful anecdotes from individuals who felt they were over-prescribed or misdiagnosed, and those are heartbreaking stories. But they don’t represent the whole picture. The data show overwhelmingly that the people who need this care benefit significantly from it — and that medical providers are doing a good job of ensuring the right people are receiving the right medical care.”

Every major medical association in the United States, including the Endocrine Society, the American Medical Association, and the American Academy of Pediatrics, supports gender-affirming care as proven and effective treatment.

Advertisement

Republicans pass ‘Big Beautiful Bill’ banning federally funded gender-affirming care for trans people

“The findings of this report support the existing expert standard of care and do not support the bans enacted thus far in 27 states,” Whitman-Walker Institute executive director Kellan Baker told The Advocate. “I think it says that they’re not actually interested in science or evidence because when they can’t predetermine the outcome of a scientific evidence review based on their political agenda, it finds that the existing standard of care is beneficial. These findings also contradict efforts to smuggle anti-trans provisions into Medicaid for transgender people of all ages via the House reconciliation bill when it was jammed through under cover of darkness last week.”

On Thursday, Republicans in Congress passed a measure forbidding federal funding for gender-affirming care under the Children’s Health Insurance Program and Medicaid. The bill also eliminates coverage for gender-affirming care under essential health benefits, even for adults with private insurance regulated under the Affordable Care Act.

If lawmakers in Utah lift the moratorium, the report recommends that the health department outline strict guardrails: a certified treatment board, licensed experts, interdisciplinary care teams, and an enhanced informed consent process. According to The Salt Lake Tribune, those recommendations are in place, but the political will is not.

Like all medical treatments, gender-affirming care is already overseen by expert physicians and follows best practices established by the World Professional Association for Transgender Health. They note that receiving this kind of care is not fast.

Now, with Utah’s own evidence confirming what trans communities and medical experts have said all along, the question is no longer whether gender-affirming care is safe. It’s whether lawmakers will admit it matters and that transgender youth deserve to live.

Advertisement

The state’s justification that the medications used aren’t FDA-approved specifically for gender dysphoria also doesn’t hold. The report emphasizes that off-label prescribing is both legal and common in pediatric medicine, especially when drugs are already approved for adults but lack industry incentives for further trials in youth.

The law’s impact has been immediate. After the ban was enacted in early 2023, the University of Utah closed its pediatric gender clinic. The Tribune notes that the same year, a state-run survey found that more than 60 percent of trans students in the state had considered suicide, with one-quarter of students having attempted it.

Utah Gov. Signs Bill Banning Most Gender-Affirming Care for Youth

Advocates warned this would happen when the law was enacted. “This is a devastating and dangerous violation of the rights and privacy of transgender Utahns,” said Chase Strangio, deputy director of the American Civil Liberties Union LGBTQ & HIV Project, at the time. “We won’t stop defending your autonomy and freedom until each and every one of you can access the care you need.”



Source link

Advertisement

Utah

Utah Jazz win coin flip, guaranteed to keep NBA Draft Lottery pick

Published

on

Utah Jazz win coin flip, guaranteed to keep NBA Draft Lottery pick


SALT LAKE CITY — The Utah Jazz missed out on the NBA Playoffs, but still scored a big win thanks to a coin flip.

In Monday’s tiebreaker coin flip to determine who had the fourth-worst record in the league last season, the Jazz came out winners over the Sacramento Kings, who had the same 22-60 record.

Had the Jazz lost the coin flip, they would have been fifth in NBA Draft Lottery odds. Only the worst four teams are guaranteed to remain within the top eight of the lottery.

If Utah had fallen to fifth, there would have been the chance they could have dropped out of the top 8 teams in the lottery, and owed the draft pick to Oklahoma City, which was top-8 protected in a previous trade.

Advertisement

The Jazz now have an 11.5 percent chance to win the first overall pick in the NBA Draft Lottery, which is scheduled for Sunday, May 10.





Source link

Continue Reading

Utah

Jazz 2026 Salary Cap Tracker: Cap Space, Contracts, Free Agents

Published

on

Jazz 2026 Salary Cap Tracker: Cap Space, Contracts, Free Agents


The Utah Jazz are rolling into a big offseason before they into what’s projected to be a wildly different-looking 2026-27 campaign from what they had just seen this past 22-win season.

But before that season is able to get underway, the Jazz have some priorities to address in the offseason––both in terms of constructing their roster and retaining a few key pieces from last year’s group into next year.

That makes their salary cap situation and everything around it important to be aware of in the next few months. So with that in mind, we’ve put together an offseason cap tracker for a glimpse of what the Jazz are dealing with in terms of cap space, contracts, and any of their own free agents hitting the open market.

Advertisement

Let’s break it down:

Maximum Possible Cap Space: $24.7M

Advertisement

Jan 30, 2026; Salt Lake City, Utah, USA; Utah Jazz Owner Ryan Smith (left) and CEO of basketball operations Danny Ainge (middle) along with president of basketball operations Austin Ainge watch warm ups before a game against the Brooklyn Nets at Delta Center. Mandatory Credit: Rob Gray-Imagn Images | Rob Gray-Imagn Images

Advertisement

The Jazz are currently projected at just under $25 million in cap headed into the summer. That’s without any additional moves made to the roster from how they’re entering the offseason, and without factoring in any free agents’ pending cap holds.

That number is bound to get smaller once the Jazz hash out their contract situation for Walker Kessler, but it could also see an uptick if Utah were to shed salary with some of their non-guaranteed deals, or any other player they wanted to pivot from.

As of now, it allows the Jazz to make a couple of moves around the edges in free agency, but the main focus will lean on signing Kessler to a long-term deal.

Contracts

Advertisement

Feb 9, 2026; Miami, Florida, USA; Utah Jazz forward Jaren Jackson Jr. (20) looks on against the Miami Heat during the second quarter at Kaseya Center. Mandatory Credit: Sam Navarro-Imagn Images | Sam Navarro-Imagn Images

A glimpse of the Jazz’s contract values for the 2026-27 season, and when they’re slated to hit free agency from their current deals:

Advertisement

– Jaren Jackson Jr.: $49.0M, ’29 PO
– Lauri Markkanen: $46.1M, ’29 UFA
– Ace Bailey: $9.5M, ’29 RFA
– Keyonte George: $6.5M, ’27 RFA
– John Konchar: $6.1M, ’27 UFA
– Cody Williams: $6.0M, ’28 RFA
– Brice Sensabaugh, $4.8M, ’27 RFA
– Svi Mykhailiuk: $3.8M*, ’28 UFA
– Kyle Filipowski: $3.0M, ’28 RFA
– Isaiah Collier: $2.7M, ’28 RFA
– Hayden Gray: $2.1M*, ’27 RFA
– Bez Mbeng: $2.1M*, ’27 RFA
– Blake Hinson (two-way), ’27 RFA

Advertisement

Total: $142.1M

*- non-guaranteed

The biggest chunk of the Jazz’s salary leans on their top two veterans, Markkanen and Jackson Jr., each making a combined $95 million next season alone.

Advertisement

However, the rest of the roster isn’t taking up much money. No one else will be making more than $10 million, and their payroll is a little less than $150 million in total.

Advertisement

Another noteworthy fact: the Jazz’s key roster pieces outside of George and Sensabaugh are all under contract through the next two seasons.

Both of the aforementioned names are also bound to see extension discussions take place this summer, which might lock in their future for even longer. 

Advertisement

Free Agents

Oct 27, 2025; Salt Lake City, Utah, USA; Utah Jazz center Walker Kessler (24) looks to pass against Phoenix Suns forward Oso Ighodaro (11) during the first quarter at Delta Center. Mandatory Credit: Rob Gray-Imagn Images | Rob Gray-Imagn Images

A look at who from this season’s roster is set to hit the free agent market in July:

– Kevin Love (UFA)
– Jusuf Nurkic (UFA)
– Walker Kessler (RFA)
– Oscar Tshiebwe (two-way)
– Elijah Harkless (two-way)

Advertisement

The biggest name of note is, of course, the Jazz’s restricted free agent big man, Walker Kessler, who Utah is bound to hand a big payday, but it remains to be seen how much that contract––or offer sheet from another team––will be.

Advertisement

Jusuf Nurkic and Kevin Love have also expressed their desire to return to the roster as they hit free agency. Re-signing both likely wouldn’t cost much for the Jazz financially, but instead relies on a question of whether the roster space is readily available to keep both.

Be sure to follow Utah Jazz On SI on X for daily Utah Jazz news, rumors and analysis!

Advertisement
Add us as a preferred source on Google



Source link

Continue Reading

Utah

Golden Knights vs. Mammoth Game 1 prediction: NHL odds, picks, best bets for Stanley Cup Playoffs

Published

on

Golden Knights vs. Mammoth Game 1 prediction: NHL odds, picks, best bets for Stanley Cup Playoffs


The Utah Mammoth is going to be a trendy underdog pick in the Stanley Cup Playoffs.

Not only does Utah have the novelty of this being its first-ever appearance in the postseason going for it, but the Mammoth tick plenty of other boxes that punters look for in a dark horse. They’re fast, dynamic, and create plenty of quality scoring chances.

The only problem is that they are running into the Vegas Golden Knights, arguably the best defensive team in the Western Conference, in Round 1.

Vegas is a -170 favorite to win the series, and it is -152 to win Game 1 on Sunday night.

Advertisement

Mammoth vs. Golden Knights odds, prediction

The Golden Knights had a weird season. Vegas started hot, took its foot off the pedal, and struggled to regain its form down the stretch. That led to a surprising coaching switch late in the campaign, but the move paid immediate dividends as John Tortorella led the Knights to a 7-0-1 record in his eight games behind the bench.

It should be noted that Tortorella benefited from an easy schedule since taking over in Vegas, but it’s hard to deny that the team looks sparked with a new voice in their ear.

What’s especially encouraging for Vegas is that its most glaring weakness, the play of goaltender Carter Hart, has started to trend in the right direction at the exact right time.

And Vegas is so good in its own zone that Hart doesn’t need to stand on his head to get the team over the line against Utah. If he’s just average, the Knights will stand a chance, especially since Utah’s goaltending situation is just as much of a question mark.


Betting on the NHL?


Outside of Vejmelka outplaying Hart, the Mammoth will also need to get this series on their terms if they want to pull the upset. Utah grades out as a slightly above-average defensive outfit, but its strength is up front with dynamic playmakers like Logan Cooley and Clayton Keller, plus sharp-shooter Dylan Guenther.

Advertisement
Logan Cooley of the Utah Mammoth. NHLI via Getty Images

For those stars to have an impact, the Mammoth will need to get Vegas to open up and engage in a back-and-forth style. I just don’t see that happening with a team that was so disciplined in its own zone all season. The Knights led the NHL in expected goals against and high-danger chances conceded at 5-on-5, which shouldn’t be a shocker given the personnel in Sin City.

Not only does Vegas boast a deep blueline, but forwards Mitch Marner and Mark Stone are regarded as two of the best defensive minds in the entire sport.

Perhaps Utah can blitz Vegas and pull the upset, but I’d need a bigger number to go against the experienced, defensively savvy Knights in a best-of-7.

And if you’re looking for a play with more upside, have a good look at Vegas to pull off the sweep at 12/1.

The Play: Vegas moneyline (-152) | Vegas to sweep the series (12/1, FanDuel)

Advertisement

Why Trust New York Post Betting

Michael Leboff is a long-suffering Islanders fan, but a long-profiting sports bettor with 10 years of experience in the gambling industry. He loves using game theory to help punters win bracket pools, find long shots, and learn how to beat the market in mainstream and niche sports.



Source link

Continue Reading
Advertisement

Trending